** Shares of biopharma co Immuron Ltd IMC.AX fall as much
as 2.5% to A$0.079
** Stock to mark worst session since Oct 3, if losses hold
** Co says signed subscription and option agreement with
UK-based gut health biotech co Ateria Health
** Deal to acquire an initial 17.5% stake in Ateria for
A$2.6 mln ($1.63 mln)
** Says deal for distribution of irritable bowel syndrome
treatment product JUVIA in Australian and North American
markets, among others
** More than 125,000 shares change hands, compared with the
30-day average volume of about 45,000
** Stock had fallen 19% this year, as of last close
($1 = 1.5952 Australian dollars)
(Reporting by Jaskiran Singh in Bengaluru)
((Jaskiran.Singh@thomsonreuters.com;))